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Figure 1: MedUse: Medication use analysis for the largest long-term study of brain development and child health in the United States.
Abstract
The RxNorm vocabulary is a yearly-published biomedical resource providing normalized names for me ications. It is used
to capture medication use in the Adolescent Brain Cognitive Development (ABCD) study, an active and publicly available
longitudinal research study following 11,800 children over 10 years. In this work, we present medUse, a visual tool allowing
researchers to explore and analyze the relationship of drug category to cognitive or imaging derived measures using ABCD
study data. Our tool provides position-based context for tree traversal and sele tion granularity of both st y participants and
drug category. Developed as part of the Data Exploration and Analysis Portal (DEAP), medUse is available to more than 600
ABCD researchers world-wide. By integrating medUse into an actively used research product we are able to reach a wide
audience and increase the practical relevance of visualization for the biomedical field.
CCS Concepts
• Human-centered computing → Information visualization; Activity centered design;
1. Introduction
The evolution of data sharing platforms into data analysis sys-
tems is driven by the complexity of the analysis required to gen-
erate publishable results, the complexity of the data shared, and
the costs involved in downloading and post-processing data. Us-
ing conventional methods to access the data generated with obser-
vational studies such as the Adolescent Brain Cognitive Develop-
ment (ABCD) study [CCC∗18], a researcher needs to download,
store, merge, and filter the available project's data. All of these data
management steps incur costs for the data sharing platform and the
individual researcher, which can hinder biomedical research. Data
sharing platforms such as the NIMH Data Archive [Nata] there-
fore add features for online data analysis such as the Data Analysis
and Exploration Portal (DEAP) [DEA]. This provides a unique op-
portunity for visualization to impact ongoing research in the fields
of developmental science and neuropsychology. The DEAP sys-
tem provides access to ABCD study data to individual researchers
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Figure 2: ABCD medication use data organized by medUse. The
data is separated into medications recognized by ATC. Individual
ATC levels are marked as L1 through L4. The label RxNorm in-
dicates the position of the captured medication names in RxNorm
nomenclature.
and performs direct hypothesis tests. Its modular design and large
user base provides a unique opportunity for new visual analysis
tools to be tested by the scientific community. In this work we have
extended DEAP, creating the first visualization-based application
focusing on the exploration of medication use data collected by
the ABCD study, a long-term study of brain development and child
health in the United States, collecting longitudinal data from 11,878
children. This data resource includes current medication use and
medication use by the mother during pregnancy captured in parent
questionnaires as structured medication names from the RxNorm
vocabulary [U.S11]. This data is shared annually as a spreadsheet
with collected medication identifiers and names as columns per par-
ticipant [ABC].
The objective of medUse is to a) enable the user of the ABCD
study to interactively browse the RxNorm coded medication use
data using a meaningful level of abstraction and to b) allow the
user to create novel scores that sum over the individual medication
entries and integrate into the DEAP system as first-class scores.
2. Related Work
The literature on tree visualization is extensive and mainly focused
on the effective use of space [KHL∗07]. Separated into space filling
and node-linked visualization methods these algorithms use a wide
range of visual organizational principles such as 2D or 3D embed-
ding [DE01], distortions [LRP95], rectangular [SCF11], radial, or
spiral arrangements [Sch11, Cui] with the goal to produce visually
pleasing graphical representations.
Space filling visualizations such as treemaps [Shn92] are more
space conserving compared to many node-linked methods. They
are well suited for displaying information located at the leaf nodes
of the hierarchy [GBP02], but they are more difficult to use for the
task of selecting non-leaf nodes in large trees. Selection and nav-
igation between neighboring nodes in the tree can result in focus
movements in both horizontal and vertical planes with distance as
the conserved organizational principle. Treemaps can be adjusted to
allow for parent labels to be displayed [LMS∗18,KH14] but exam-
ples presented in those implementations suggest that they are more
tailored for short labels. Support for a focused display of labels at
different scales has been suggested [KvK∗19]. Using camera dis-
tance and occlusion to selectively show and position hierarchical
labels of multi-instance objects for volumetric displays.
Focus and context approaches have been suggested to help users
to show particular tree nodes while providing context for the place-
ment of the node in the hierarchy [LRP95, SCF11]. The 2D dis-
tortion introduced to highlight a focus point in the graph can be
severe and require global changes in the visual representation dur-
ing navigation. Focus and context approaches can also be applied to
more traditional approaches for displaying large hierarchical struc-
tures such as indented lists [SQX∗06]. The large available horizon-
tal space is ideal for longer node names but is more difficult for the
user to navigate and highlight the current location without extensive
mouse or keyboard interactions.
The RxNav browser is a web application for exploring the
RxNorm and ATC classification schemes [ZBKN06]. The soft-
ware supports a class view visualization that supports zoom and
pan after searching for a specific medication name. Only a sin-
gle parent chain from a single medication is displayed. Naviga-
tion to neighboring nodes is cumbersome as it involves repeated
folding operation using drop-down menus. The tool does not al-
low the user to visualize medication data for a study cohort. An
interesting service that allows computations on study cohort data is
RxMix [PMNB13]. RxMix provides a graphical user interface to
compose medication data specific processing pipelines. Applied to
user-provided lists of medications such a pipeline can, for example,
translate between different medical nomenclatures.
3. Tasks
A typical analysis using the ABCD data resource would look at
medication use behavior or psychological and cognitive side effects
of classes of medications. Assigning the class labels to each par-
ticipant in the cohort the researcher compares multi-dimensional
class assignments statistically. For example, if there is a correla-
tion between the reported use of ADHD medications and a cogni-
tive outcome measure that correlates with attention or short-term
memory. The large number of similar prescriptions and brand and
generic versions of the same drug requires significant effort and ex-
pertise for the researcher to derive medication classes for such a
system level analysis. For ADHD related medications, for example,
our tool reports that there are 53 individual medications selected
by the parents. As the study includes healthy kids, a large number
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Table 1: ACT classification for the medication Adderall by organ system, therapeutic use, pharmacological subgroup, and chemical sub-
group. An additional ATC level 5 for chemical substances is not used to simplify the overall tree layout.
level principle use class id node name
root Medications
drug in ATC Anatomical Therapeutic Chemical (ATC1-4)
1 organ system N Nervous System
2 therapeutic subgroup N06 Psychoanaleptics
3 pharmacological subgroup N06B Psychostimulants, Agents used for ADHD and Nootropics
4 chemical subgroup N06BA Centrally acting sympathomimetics
RxNorm ABCD captured medication 84815 Adderall
of research topics would benefit from the inclusion of medication
data. The effort required to generate, document and update these
manual classifications prompted the development of our medUse
application.
4. Approach
To support research in the field of developmental science and neu-
ropsychology we selected the Anatomical Therapeutic Chemical
Classification System (ATC) [Wor], an ontology that provides in-
formation to group individual medications hierarchically by organ
system, the mechanism of action or therapeutic use, and by phar-
macological and chemical subgroup (see Table 1).
The ATC classification system provides a fixed depth of five hier-
archy levels. We introduce one additional level to include the more
than 800 observed RxNorm medication types in Figure 2. Using a
data-driven generation of the medication class hierarchy we limit
the ATC classifications to entries that have at least one reported
medication use in the selected group of study participants. For med-
ication items that belong to multiple ATC classes the specific ther-
apeutic use is unclear, so we use multiple assignments to allow for
a correct statistical coverage of the multiple choices. This approach
leads to a combined tree with more than 1,000 nodes and an aver-
age branching factor of 24 (see Figure 2).
For visualization-naive users, the main target group of medUse,
we developed a four-point navigation paradigm to guide naviga-
tion. This allows for more control by separating movements in the
horizontal direction to indicate class specificity from movement
vertically in the tree to select alternative drug classes at the same
specificity (Figure 3). To support class comparison across differ-
ent branches we changed the default navigation strategy, allowing
users to move between branches using the Up and Down arrow nav-
igation (see example in Figure 3). Each branching node also tracks
the last navigation choice as the user traverses the tree (right to
left). If the navigation direction is reversed, the previously recorded
choice is selected during tree traversal. Both of these changes in-
crease saliency of user choice and can prevent feelings of being
lost after navigation steps. Overall, this four-point navigation sys-
tem supports the user in recovering already visited nodes in the
tree. Limiting the mental load required to perform the task medUse
attempts to improved the overall user satisfaction. For experienced
users we also included a full text search as a drop-down option. This
allows them to navigate quickly to a specific location, providing a
method to ignore hierarchical information and instead search for
keywords found in node descriptions. Our application supports all
combinations of the available navigation modes i) mouse/touch, ii)
keyboard/cursor, and iii) text searches and updates all components
of the user interface accordingly for maximum view flexibility.
Based on its intended use, one medication item is always dis-
played in the center of the screen. From there it can be exported
as a binary classification vector coding 1 for study participants at a
given visit that had at least one medication use reported for the class
and 0 otherwise. With the integration of medUse into the DEAP ap-
plication this new data vector becomes part of the ABCD study data
and is available in the statistical modules of DEAP.
An active class level removes the need for frequent mouse clicks
to select a new level for inspection and provides automatic updates
of context information during all navigation steps. The informa-
tion presented includes access to online documentation as well as
textual and visual summary information for the number of partici-
pants selected by the current class, as depicted in Figure 1 and using
color to indicate the current class level. This allows the user to eas-
ily judge the specificity of the selection during the navigation step.
Sorting the branches of the tree by the number of the participants
reporting drug use, the most frequent used medication class appears
near the top of the tree, whereas less frequently used medications
are grouped closer to the bottom. Navigation from parent nodes to
child nodes favors the top branches with the most frequently re-
ported medication classes. The height of the selected location in
the medication tree therefore has meaning in the context of the user
task of finding an appropriate class for analysis.
4.1. Implementation
MedUse is implemented as a single-page web-application utilizing
the DEAP user authentication and authorization framework. This
ensures that users with valid access to the project data also have
access to the application. The integration as a DEAP component
allows the application to focus on a single workflow leading to a
cleaner interface design. Other DEAP components are contacted
by medUse to add derived data to the data dictionary and saving
co-variate data accessible to the statistical analysis tool.
Whereas access to the study data is provided by the DEAP
framework, the hierarchical ATC data is downloaded from the Na-
tional Library of Medicines ATC web-API [Natb] as JSON en-
coded text and cached by the user's client browser to improve the
© 2019 The Author(s)
Eurographics Proceedings © 2019 The Eurographics Association.










Figure 3: (Top) Example focus information for Melatonin linking
to search field and list of alternative uses and touch/mouse enabled
four-point navigation fields (right). (Bottom) Navigation example
omitting the display of actual node labels for clarity. Current loca-
tion is marked with (+). The four node-linked neighboring positions
in the tree are Left (level L2), Right (e.g. R1, L4), and Down (L3).
The Up position (L3) is local only relative to the selected ATC level
3, but not local given the ATC hierarchy.
startup time of the application. All data manipulations are imple-
mented client-side in JavaScript. This limits the requirements on
the DEAP server infra-structure and allows the application to scale
to a large number of simultaneous users. The tree visualization is
implemented using the D3.js library [BOH11]. Focus-level infor-
mation was added as additional HTML/CSS elements placed on
top of the tree at a fixed screen location. During navigation the fo-
cus level information is updated and the tree view moves so that the
new selection is in the center of the browser window. Animations
are used to move the tree improving the user's location awareness.
5. User Study and Feedback
To test the usability of the application we asked 3 researchers to
participate in a user test. They were familiar with the DEAP anal-
ysis system but unfamiliar with medUse. They had varying levels
of expertise in analyzing medication use data. We instructed them
to create a regression model analyzing the effects of brain struc-
tures on cognitive measures while correcting for reported medica-
tion use related to attention deficit hyperactivity disorder (ADHD).
The task required them to create the summary measure for ADHD
medication in medUse and to use the generated score in another
DEAP application. All users did understand the hierarchical visu-
alization using a node-linked tree and appreciated the level of detail
it provides for individual medications in relation to the therapeuti-
cal subgroups.
Hypothesis generation in the DEAP statistical analysis involves
the combination of multiple measures. We manually reviewed the
variability of the user-generated hypotheses and observed a pref-
erence of experts for adding medUse generated medication groups
at varying levels of specificity. Overall they tended to generate less
than 10 alternative analysis models. MedUse supports the docu-
mentation of this user choice by generating fixed names for the ex-
ported medication use measures based on the name for the node in
the tree. Sharing of the hypothesis specification on DEAP is there-
fore sufficient for other users to replicate ABCD findings related to
medication use.
Our tool allowed the ABCD test users to visually explore hi-
erarchical relationships on medication use for parents (during
pregnancy) and youth by navigating from the most general class
(drug/supplement or no-drug) down to individual medications. This
is done in the context of a study participant cohort dataset that is in-
terpreted and visualized with the help of the ATC ontology. This is
in contrast to many previous approaches on graph visualization for
ontological data [KHL∗07] that focus on the ontology itself, with-
out regard to a specific task in which that ontology is utilized.
Based on results from the user studies medUse is well suited
to support visualization naive users in the selection of medication
classification groups from the ATC ontology. Users tend to use a
single navigation style and readily adopt the four-point navigation
using the keyboard without additional training (see user study). Test
users not familiar with the nomenclature used to identify medica-
tion use data or the classification system for organ specific or thera-
peutic uses of such medications have nevertheless been able to use
medUse successfully. Compared to a manual re-coding of the med-
ication information, the medUse approach is less error prone and
can be repeated easily to include other medication classes. MedUse
fully automates the mapping of data to the ATC ontology and can
be used by users not trained in the classification of individual med-
ications.
6. Discussion and Conflusions
MedUse makes assumptions that might limit its use for analyzing
other medication related information. First of all, the restriction of
only supporting a single classification system limits the choice for
the user. One might argue that this reduces researcher degrees of
freedom, but this is unhelpful if a required medication grouping
is not supported. The application cannot be used to create arbitrary
user defined classifications. A possible extension of medUse to sup-
port alternative ontologies are possible and requires further discus-
sion. MedUse also limits itself to the display of ontology elements
relevant for a specific data set. It cannot be used to explore branches
in the ontology that are not supported by the current data in the
study. There are also problems associated with the use of the ATC
classification. According to the WHO [Wor], ATC codes are as-
signed frequently according to the mechanism of action rather than
the therapy. Medication groups can therefore include medicines for
different indications, and medicines with similar therapeutic use
may be classified in different groups. MedUse tries to support these
ambiguities with highlighting multi-use medications.
The need to zoom in order to localize visually the current class
in relation to the overall ATC hierarchy can be problematic. At low
zoom factors the hierarchy is visible, but font-sizes are scaled down
and ATC text entries become unreadable. This favors desktop users
with larger screen sizes and is not an issue for users that explore the
hierarchy locally at higher zoom factors, or for users that use full-
text search to navigate larger ATC distances in the tree. It would
have been possible to add additional visualization components to
provide two simultaneous level of detail or geometric distortions,
but the benefits of such an addition may not outweigh the risk in-
volved with making the user interface more complex, and therefore
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less approachable for the target audience. It is worthwhile to ex-
plore dynamic labeling approaches in more detail as they can re-
duce visual complexity at different zoom levels.
As the ABCD study releases more data we plan to continue op-
timizing and extending this visualization tool to support futher re-
search in developmental science and neuropsychology.
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